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Background: Patients with a patent foramen ovale have a high prevalence of migraine with aura (MA). However,
whether patients with an atrial septal defect (ASD) have a high prevalence of migraine remains unclear. The present
study aimed to determine the prevalence of migraine and its clinical characteristics in patients with ASD.
Findings: Ninety-five patients (age ≥ 20 years) who had undergone percutaneous ASD closure responded to a
questionnaire used by neurologists to diagnose migraine either with or without aura. We diagnosed migraine
before ASD closure according to the criteria of the International Headache Society. The overall prevalence of
migraine seemed to be higher in the present study than in the Japanese general population (24.2% vs. 9.4%,
respectively). All patients with MA were female and significantly younger than those without migraine (p < 0.01).
Conclusions: Our findings suggested that the susceptibility to the development of MA differs according to sex and
age in patients with cardiac shunt.
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Patients with a patent foramen ovale (PFO) have a
high prevalence of migraine with aura [1,2]. A right-
to-left shunt (RLS) might be implicated in the patho-
genesis of this disorder [3]. However, whether patients
with atrial septal defect (ASD) have a high prevalence
of migraine remains unclear. This might be because
ASD is relatively rare (1–3 cases per 10,000 births)
compared with PFO [4]. We recently reported the in-
fluence of percutaneous ASD closure on migraine and
found de novo migraine in 11% of that study popula-
tion [5]. In addition, a high prevalence of migraine was
noted in that study before ASD closure [5]. In the
present study, we focused on the effect of sex and age
on the prevalence of migraine in patients with ASD
and evaluated the clinical characteristics of migraine
in these patients.* Correspondence: yujik@saitama-med.ac.jp
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Patient selection
ASD was diagnosed by transesophageal echocardiography
and cardiac catheterization. All patients aged ≥20 years
who were included in our previous study and underwent
transcatheter ASD closure at our center between August
2005 and March 2012 responded to a questionnaire that
neurologists used to diagnose migraine either with or
without aura (MA or MO, respectively). The questionnaire
was constructed in accordance with the International
Classification of Headache Disorders, 2nd edition [6].
The questionnaire was mailed to all patients from May
2012 to March 2013. The time interval from closure to
questionnaire administration was 39 ± 19 months (range:
3 to 80 months). Migraine prevalence before ASD closure
was compared with that reported in the Japanese general
population [7], after adjustment for sex and age. The
present study proceeded in accordance with our institu-
tional ethics committee, and all patients and/or their rela-
tives provided written, informed consent to participate in
the study.
Statistical analysis
Quantitative variables are expressed as means ± standard
deviation, and qualitative variables are expressed as ratiosOpen Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
Table 1 Migraine prevalence by sex and age in patients
with ASD (above) and published data for the general
population in Japan (below)




Male 20-29 4 0 (0) 1 (25.0)
30-39 3 0 (0) 2 (66.7)
40-49 13 0 (0) 0 (0)
50-59 4 0 (0) 0 (0)
60-69 3 0 (0) 0 (0)
70+ 1 0 (0) 0 (0)
Total 28 0 (0) 3 (10.7)
95% CI 28 0-12.1 3.7-27.2
Female 20-29 11 2 (18.1) 2 (18.1)
30-39 15 3 (20.0) 5 (33.3)
40-49 9 1 (11.1) 0 (0)
50-59 19 0 (0) 7 (36.8)
60-69 10 0 (0) 0 (0)
70+ 3 0 (0) 0 (0)
Total 67 6 (9.0) 14 (20.9)
95% CI 67 4.2-18.2 12.9-32.1
Total 95 6 (6.3) 17 (17.9)
95% CI 95 2.9-13.1 11.5-26.8
General population
Male 2,670 0.4* 2.4*
Female 3,070 1.3* 10.8*
Total 5,740 1.1* 8.3*
Values are shown as numbers (%). *Adjusted for sex and age distribution.
Abbreviation: CI confidence interval.
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flow ratio (Qp/Qs) were compared across groups using
the Wilcoxon rank-sum test. Differences were considered
statistically significant when p < 0.05. Data were analyzed
using PASW Statistics software version 18 (SPSS, Inc.,
Chicago, IL).
Findings
Among the 95 patients (response rate 79%) who partici-




Age 47.5 ± 14.7 46.4 ± 13.2
Female sex, n (%) 47 (65) 0 (0)
ASD diameter (mm) 19.5 ± 5.3 19.5 ± 6.3
Qp/Qs 2.6 ± 1.3 2.4 ± 1.4
*p < 0.01 vs. no migraine female; Qp/Qs, pulmonary to systemic blood flow ratio.there were 67 females. The prevalence of migraine was
10.7% (0% MA and 10.7% MO) and 29.9% (9.0% MA
and 20.9% MO) in men and women, respectively. The
overall prevalence of migraine was 24.2% (6.3% MA and
17.9% MO). The 95% confidence interval (CI) of mi-
graine prevalence ranged from 16.7% to 33.7%. Table 1
shows the prevalence of migraine in each age group for
both sexes.
The study population was divided into groups consisting
of patients without migraine and those with MA or MO,
and their characteristics are shown in Table 2. Patients
with MA were significantly younger than those without
migraine (p < 0.01), and women tended to develop MA
more frequently than men; however, the difference did not
reach statistical significance.
Discussion
Patients with ASD had a 1.8- to 3.6-fold higher prevalence
of migraine (24.2%; 95% CI, 16.7 - 33.7%) than the 9.4%
found in the Japanese general population after adjusting
for sex and age [7]. Compared with the Japanese general
population, there was a 6.9-fold higher prevalence of MA
in women, and a 4.5- and 1.9-fold higher prevalence of
MO in men and women, respectively [7]. The group
with MA was exclusively female and these patients were
younger than females who did not have migraine. These
findings suggest that susceptibility to MA differs according
to sex and age in the presence of a cardiac shunt. The
mechanism for a sex difference in migraine could be
mediated by fluctuations in estrogen levels via their in-
fluence on cellular excitability or the cerebral vascu-
lature [8]. The large CI in our sample represented
uncertainty due to the small number of patients in
each group.
The reported prevalence of migraine in patients with
ASD ranges from 11 to 22% for MA and 12 to 28% for
MO [9-12]. In contrast, we found a lower prevalence of
MA (6.3%) but a similar prevalence of MO (17.9%) in
our cohort of 95 patients. Although we found MA only
in females, sex has never been reported to be associ-
ated with migraine type (MA or MO) in previous stud-
ies of patients with ASD. Mortelmans et al. reported a
total migraine prevalence of 30% in ASD patients, andbefore ASD closure
Migraine Migraine
Female With aura Without aura
47 6 17
48.1 ± 15.6 32.5 ± 5.4* 41.1 ± 12.4
47 (100) 6 (100) 14 (82)
19.4 ± 4.8 17.4 ± 7.4 19.4 ± 5.2
2.7 ± 1.2 2.9 ± 1.7 2.6 ± 0.9
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graine [9]. They considered that MA in older patients
could be associated with a right-to-left shunt (RLS)
through an ASD, as they might be more prone to
thrombus formation in the venous circulation [9]. In
contrast, patients with MA were younger than those
without migraine in the present study. This is similar
to the age distribution of migraine patients in a popu-
lation with PFO [13].
An ASD is mainly characterized by a left-to-right
shunt. However, contrast echocardiography can detect
an RLS during a Valsalva maneuver or exercise in pa-
tients with an ASD [14]. An RLS can also allow blood
to bypass the lung filter. Microemboli and vasoactive
chemicals such as serotonin might be potential mi-
graine triggers. Alternatively, the inheritance of com-
mon genetic factors for cardiac defects and MA has
been suggested. The common inheritance of atrial
shunts including ASD with MA has been observed in
some families [15].
In our previous study, we found an increase in the
overall prevalence of migraine after ASD closure [5].
Nevertheless, in several patients, migraine disappeared
after ASD closure [5]. Platelet aggregation possibly on
the left side of the device or intra-atrial pressure im-
balance after ASD closure might unmask a migrainous
diathesis. Younger patients had a higher prevalence of
migraine with aura before ASD closure, but some
other patients developed de novo migraine after ASD
closure.
Our study does have a few limitations. First, selection
bias might be present because our patient population
was selected from a cohort referred to our center for
percutaneous ASD closure. Second, this retrospective
study asked patients about their headache after ASD
closure, and remembering the characteristics of head-
aches might have been difficult for some because of the
long time interval (range: 3 to 80 months) from ASD
closure to completion of the questionnaire. Therefore,
recall bias might have been introduced. To minimize this
potential confounding factor, we confirmed the occur-
rence of migraine in patients’ medical records. Third,
we need to consider racial variations in migraine preva-
lence, as the prevalence of migraine is lower in Japan
than in Western countries [16,17]. Fourth, our study
lacked a control group and we compared our results
with previously published results in the general Japanese
population [7].Consent
Written informed consent was obtained from the patient
for the publication of this report and any accompanying
images.Abbreviations
PFO: Patent foramen ovale; ASD: Atrial septal defect; RLS: Right-to-left shunt;
MA: Migraine with aura; MO: Migraine without aura.
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